Yolande Marie Eckrich , PA-C
Physician Assistant • Davenport, FL
2504 Sand Mine Rd
Davenport, FL 338973402
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Yolande Eckrich is listed in NPPES under Physician Assistant.
-
NPI assigned on October 9, 2017; this date does not establish years in practice.
-
Published CMS data list 1,209 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Buspirone Hcl — 179 prescription fills, including refills.
- Trazodone Hcl — 91 prescription fills, including refills.
- Escitalopram Oxalate — 62 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 60% of clinicians listed under Physician Assistant in Davenport, FL (2024, 12 clinicians with data). Median for this group: 651. Middle half: 183 to 1,547.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant in Florida (2024, 4,894 clinicians with data). Median for this group: 270. Middle half: 78 to 825.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 218 in 2020 to 1,209 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
2504 Sand Mine Rd
Davenport, FL 338973402
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician Assistant: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,209 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$26,315 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $943.63 across 57 records.
By nature of payment
- Food and Beverage: $943.63 across 57 records.
Reporting-company totals (3 largest of 13)
- Otsuka America Pharmaceutical, Inc.: $243.04 across 19 records.
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.): $220.00 across 15 records.
- Vanda Pharmaceuticals Inc.: $80.55 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2017
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Davenport and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Physician Assistant in Davenport, FL (2024, 12 clinicians with data). Median for this group: 651. Middle half: 183 to 1,547.
More Part D prescriptions than 80% of clinicians listed under Physician Assistant in Florida (2024, 4,894 clinicians with data). Median for this group: 270. Middle half: 78 to 825.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Physician Assistant in Davenport, FL (2024, 12 clinicians with data). Median for this group: $8,723. Middle half: $1,006 to $166,846.
A higher Part D drug cost than 65% of clinicians listed under Physician Assistant in Florida (2024, 4,894 clinicians with data). Median for this group: $5,225. Middle half: $703 to $70,250.
26 active clinicians are listed under Physician Assistant with a practice address in Davenport, FL (10,260 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Davenport
11.5% of these 26 clinicians have the CMS telehealth indicator.
34.6% of these 26 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 455% from 218 in 2020 to 1,209 in 2024.
- 2020: 218
- 2021: 2,635
- 2022: 1,113
- 2023: 1,540
- 2024: 1,209
-
30-day fills
30-day fills increased 606% from 313 in 2020 to 2,209 in 2024.
- 2020: 313
- 2021: 3,741
- 2022: 1,534
- 2023: 2,403
- 2024: 2,209
-
Part D drug cost
Part D drug cost increased 316% from $6,320 in 2020 to $26,315 in 2024.
- 2020: $6,320
- 2021: $203,358
- 2022: $24,114
- 2023: $29,663
- 2024: $26,315
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $143.37 in 2021 to $943.63 in 2025.
- 2021: $143.37
- 2022: $2,069.31
- 2023: $599.06
- 2025: $943.63
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 57 records totaling $943.63.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $28.02 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $27.94 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $26.34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $26.05 |
| Eisai Inc. |
Food and Beverage
In-kind items and services
|
Leqembi | General | $25.78 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $25.24 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $25.23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $24.16 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ZAVZPRET | General | $23.99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $23.11 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $22.76 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $22.40 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $22.38 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $21.99 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SPRAVATO | General | $21.71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $21.58 |
| ARGENX US, INC. |
Food and Beverage
In-kind items and services
|
VYVGART HYTRULO | General | $21.47 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
FANAPT | General | $20.96 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $20.74 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $20.45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $20.08 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $20.05 |
| Merz Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
INBRIJA | General | $19.59 |
| ACADIA Pharmaceuticals Inc |
Food and Beverage
In-kind items and services
|
NUPLAZID | General | $19.13 |
| Lundbeck LLC |
Food and Beverage
Cash or cash equivalent
|
REXULTI | General | $18.92 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Buspirone Hcl | Buspirone Hcl | 179 | 10,327 | $3,344.60 | 44 |
| Trazodone Hcl | Trazodone Hcl | 91 | 5,430 | $804.24 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 62 | 4,169 | $821.93 | 14 |
| Memantine Hcl | Memantine Hcl | 62 | 3,270 | $4,626.79 | 11 |
| Lorazepam | Lorazepam | 53 | 1,784 | $313.60 | 12 |
| Sertraline Hcl | Sertraline Hcl | 52 | 3,240 | $436.53 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 52 | 3,240 | $1,176.87 | 18 |
| Clonazepam | Clonazepam | 51 | 1,475 | $455.51 | — |
| Mirtazapine | Mirtazapine | 51 | 2,730 | $1,449.68 | 15 |
| Bupropion Xl | Bupropion Hcl | 49 | 3,150 | $1,378.28 | 16 |
| Alprazolam | Alprazolam | 44 | 1,290 | $275.20 | — |
| Fluoxetine Hcl | Fluoxetine Hcl | 44 | 3,000 | $383.11 | — |
| Donepezil Hcl | Donepezil Hcl | 43 | 3,210 | $916.65 | 11 |
| Temazepam | Temazepam | 41 | 1,220 | $485.89 | — |
| Duloxetine Hcl | Duloxetine Hcl | 37 | 2,550 | $1,116.30 | 13 |
| Lamotrigine | Lamotrigine | 34 | 1,753 | $482.80 | — |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | 1,470 | $501.56 | — |
| Aripiprazole | Aripiprazole | 28 | 1,920 | $648.09 | — |
| Olanzapine | Olanzapine | 23 | 1,065 | $431.36 | — |
| Bupropion Hcl Sr | Bupropion Hcl | 22 | 1,620 | $560.71 | — |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 21 | 545 | $1,840.02 | — |
| Paroxetine Hcl | Paroxetine Hcl | 20 | 1,556 | $498.87 | — |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | 1,110 | $1,259.09 | — |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | 1,080 | $522.26 | — |
| Rivastigmine | Rivastigmine Tartrate | 17 | 510 | $637.10 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 363A00000X
A physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Physician Assistant
Nurse Practitioner
Advanced Practice Registered Nurse, Licensed Clinical Social Worker
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated October 09, 2017.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from November 2017 to August 2026.
NPI Administrative Meta
Other Physician Assistants in Davenport
- Francisco Cortes, PA
- Eric Cole, PA-C
- Kelsey Schaeffer, PA-C
- Jacob Wonderlich, PA
- Kathryn Kuscavage, PA-C
- Sehrish Khurram
Mailing Address
4600 Holly Branch Dr Apt 903
Orlando, FL 328117117